Standard Biotools (LAB) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 16.91% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.77% |
| Mar 31, 2026 | 61.87% |
| Dec 31, 2025 | -12,303.52% |
| Sep 30, 2025 | -567,676.16% |
| Jun 30, 2025 | -108,238.23% |
| Mar 31, 2025 | -533.33% |
| Dec 31, 2024 | -102.36% |
| Sep 30, 2024 | 95.12% |
| Jun 30, 2024 | 84.65% |
| Mar 31, 2024 | 94.02% |
| Dec 31, 2023 | 85.12% |
| Sep 30, 2023 | 56.20% |
| Jun 30, 2023 | 52.55% |
| Mar 31, 2023 | 6.40% |
| Sep 30, 2022 | -32.92% |
| Jun 30, 2022 | -58.72% |
| Mar 31, 2022 | 2.65% |
| Sep 30, 2021 | -25,907.26% |
| Jun 30, 2021 | -10,475.53% |
| Mar 31, 2021 | -4,358.44% |